Advertisement
more top stories »

Antiviral


— Medical

New compound triggers immune response to range of RNA viruses, including Ebola and hep C

Though important advances have been made in treating RNA virus infections such as hepatitis C and influenza, a broad spectrum antiviral drug that throws a blanket over all of them, including more deadly variants like Ebola, has remained out of reach. Scientists are now reporting the discovery of a drug-like molecule that could be used to combat all RNA viruses, by triggering an innate immune response that suppresses and controls the infections.

Read More

Self-disinfecting mobile displays could be less than two years away

According to a study conducted for Which? magazine in 2010, the surface of the average mobile phone contains 18 times the amount of harmful bacteria as a flush lever in a mens’ public toilet. Other studies have come up with other numbers, but the phone always comes out the dirtier of the two. To that end, Corning is now developing antimicrobial glass, which may be killing germs on your phone’s display within two years. Read More
— Health and Wellbeing

FDA approves first drug to prevent HIV infection

While there are many methods for preventing HIV transmission that work in principle (abstinence, safe sex, monogamy to some extent), in practice efforts to prevent new HIV infections have reached a plateau - about 50 thousand new cases are reported every year in the United States and no progress has been made on reducing this number for at least 15 years, with the overall rate of infection remaining stable since at least 2004. In response to the almost complete lack of effective prevention methods, the U.S. FDA (Food and Drug Administration) has now approved the prophylactic use of the anti-retroviral combination drug Truvada, to reduce the risk of people acquiring HIV. Read More
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement